ATYR
aTyr Pharma
ATYR
ATYR
40 hedge funds and large institutions have $58.7M invested in aTyr Pharma in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
24% less capital invested
Capital invested by funds: $77M → $58.7M (-$18.4M)
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Holders
40
Holding in Top 10
1
Calls
$49K
Puts
$8K
Top Buyers
| 1 | +$2.31M | |
| 2 | +$653K | |
| 3 | +$507K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$395K |
| 5 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$88.3K |
Top Sellers
| 1 | -$663K | |
| 2 | -$519K | |
| 3 | -$423K | |
| 4 |
Two Sigma Advisers
New York
|
-$300K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$153K |